David A. Bonderer

Array ( [id] => 6383132 [patent_doc_number] => 20020120139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Pyrimidinone compounds and pharmaceutical compositions containing them' [patent_app_type] => new [patent_app_number] => 10/115452 [patent_app_country] => US [patent_app_date] => 2002-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62933 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20020120139.pdf [firstpage_image] =>[orig_patent_app_number] => 10115452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1126968 [patent_doc_number] => 06790850 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-14 [patent_title] => 'Thiazolo(4,5-d)pyrimidine compounds' [patent_app_type] => B1 [patent_app_number] => 10/089571 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18897 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790850.pdf [firstpage_image] =>[orig_patent_app_number] => 10089571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 699733 [patent_doc_number] => 07067657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Thiazolopyrimidine derivatives and use thereof as antagonists of the CX3 CR1 receptor' [patent_app_type] => utility [patent_app_number] => 10/472992 [patent_app_country] => US [patent_app_date] => 2002-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7398 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 753 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067657.pdf [firstpage_image] =>[orig_patent_app_number] => 10472992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1021782 [patent_doc_number] => 06887873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-03 [patent_title] => 'Triazine derivatives and their application as antitelomerase agents' [patent_app_type] => utility [patent_app_number] => 10/103883 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15360 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887873.pdf [firstpage_image] =>[orig_patent_app_number] => 10103883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6330029 [patent_doc_number] => 20020198237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Heterocyclic compounds' [patent_app_type] => new [patent_app_number] => 10/104283 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24368 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198237.pdf [firstpage_image] =>[orig_patent_app_number] => 10104283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1062955 [patent_doc_number] => 06849621 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-01 [patent_title] => 'Piperidine compounds' [patent_app_type] => utility [patent_app_number] => 10/095134 [patent_app_country] => US [patent_app_date] => 2002-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11709 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849621.pdf [firstpage_image] =>[orig_patent_app_number] => 10095134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1229838 [patent_doc_number] => 06692562 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Process for making perylene pigment compositions' [patent_app_type] => B2 [patent_app_number] => 10/093546 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6026 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692562.pdf [firstpage_image] =>[orig_patent_app_number] => 10093546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6675042 [patent_doc_number] => 20030060645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Polymorphic and other crystalline forms cis-FTC' [patent_app_type] => new [patent_app_number] => 10/086830 [patent_app_country] => US [patent_app_date] => 2002-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8584 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060645.pdf [firstpage_image] =>[orig_patent_app_number] => 10086830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329916 [patent_doc_number] => 20020198224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Method for the synthesis of 2\',3\'-dideoxy-2\',3\'-didehydronucleosides' [patent_app_type] => new [patent_app_number] => 10/087112 [patent_app_country] => US [patent_app_date] => 2002-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31088 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198224.pdf [firstpage_image] =>[orig_patent_app_number] => 10087112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6756362 [patent_doc_number] => 20030004139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors' [patent_app_type] => new [patent_app_number] => 10/085609 [patent_app_country] => US [patent_app_date] => 2002-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17222 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004139.pdf [firstpage_image] =>[orig_patent_app_number] => 10085609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386943 [patent_doc_number] => 20040029854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Nirtic oxide donors based on metallic centres' [patent_app_type] => new [patent_app_number] => 10/399408 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4381 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029854.pdf [firstpage_image] =>[orig_patent_app_number] => 10399408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874863 [patent_doc_number] => 20030195160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Sodium channel blockers' [patent_app_type] => new [patent_app_number] => 10/076551 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16587 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20030195160.pdf [firstpage_image] =>[orig_patent_app_number] => 10076551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809517 [patent_doc_number] => 20030199456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Sodium channel blockers' [patent_app_type] => new [patent_app_number] => 10/076571 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22705 [patent_no_of_claims] => 124 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199456.pdf [firstpage_image] =>[orig_patent_app_number] => 10076571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056605 [patent_doc_number] => 06855829 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-15 [patent_title] => '3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease' [patent_app_type] => utility [patent_app_number] => 10/075703 [patent_app_country] => US [patent_app_date] => 2002-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13105 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855829.pdf [firstpage_image] =>[orig_patent_app_number] => 10075703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6658286 [patent_doc_number] => 20030078276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Matrix metalloproteinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/075069 [patent_app_country] => US [patent_app_date] => 2002-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 48699 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078276.pdf [firstpage_image] =>[orig_patent_app_number] => 10075069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1246025 [patent_doc_number] => 06677355 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors' [patent_app_type] => B1 [patent_app_number] => 10/049544 [patent_app_country] => US [patent_app_date] => 2002-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14665 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 294 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677355.pdf [firstpage_image] =>[orig_patent_app_number] => 10049544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6548917 [patent_doc_number] => 20020137926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Process for preparing crystalline salts of amoxycillin' [patent_app_type] => new [patent_app_number] => 10/074824 [patent_app_country] => US [patent_app_date] => 2002-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2573 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137926.pdf [firstpage_image] =>[orig_patent_app_number] => 10074824 [rel_patent_id] =>[rel_patent_doc_number] =>)